Show simple item record

dc.contributor.authorHorvath, Thomas D
dc.contributor.authorYılmaz, Vuslat
dc.contributor.authorTüzün, Erdem
dc.contributor.authorHaag, Anthony M
dc.contributor.authorVersalovic, James
dc.contributor.authorEngevik, Melinda A
dc.contributor.authorKürtüncü, Murat
dc.contributor.authorTürkoğlu, Recai
dc.contributor.authorPalacio, Jeremy
dc.contributor.authorThapa, Santosh
dc.contributor.authorHoch, Kathleen M
dc.contributor.authorHaidacher, Sigmund J
dc.contributor.authorAkbayir, Ece
dc.contributor.authorOezguen, Numan
dc.date.accessioned2023-02-21T07:21:04Z
dc.date.available2023-02-21T07:21:04Z
dc.date.issued2022
dc.identifier.citationOezguen N., Yılmaz V., Horvath T. D., Akbayir E., Haidacher S. J., Hoch K. M., Thapa S., Palacio J., Türkoğlu R., Kürtüncü M., et al., "Serum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios.", Multiple sclerosis and related disorders, cilt.68, sa.1, ss.104239, 2022
dc.identifier.issn2211-0348
dc.identifier.othervv_1032021
dc.identifier.otherav_04a2009e-7380-44a2-8a35-76a3854751de
dc.identifier.urihttp://hdl.handle.net/20.500.12627/185722
dc.identifier.urihttps://doi.org/10.1016/j.msard.2022.104239
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S221103482200743X?dgcid=coauthor
dc.language.isoeng
dc.subjectSağlık Bilimleri
dc.subjectKlinik Tıp (MED)
dc.titleSerum 3-phenyllactic acid level is reduced in benign multiple sclerosis and is associated with effector B cell ratios.
dc.typeMakale
dc.relation.journalMultiple sclerosis and related disorders
dc.contributor.department, ,
dc.identifier.volume68
dc.identifier.issue1
dc.identifier.startpage104239
dc.identifier.endpage104239
dc.contributor.firstauthorID4079775


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record